methenolone has been researched along with Remission--Spontaneous* in 8 studies
1 review(s) available for methenolone and Remission--Spontaneous
Article | Year |
---|---|
[Androgens in treatment of acquired bone marrow aplasia].
Topics: Age Factors; Aged; Androgens; Anemia, Aplastic; DNA; Erythropoietin; Female; Hematopoiesis; Humans; Male; Methenolone; Oxymetholone; Prognosis; Remission, Spontaneous; RNA; Testosterone | 1973 |
1 trial(s) available for methenolone and Remission--Spontaneous
Article | Year |
---|---|
Treatment of refractory anemias with methenolone.
A therapeutic trial with methenolone (Primobolan) in 19 consecutive patients with different types of refractory anemia is reported. The remission frequencies were: pancytopenia 3/6, bicytopenia 2/4, refractory anemia with hyperplastic marrow 1/5, myelofibrosis 1/4. There was no obvious prolongation of survival in the patients responding. Side-effects were negligible. Topics: Aged; Agranulocytosis; Anemia, Aplastic; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Liver; Male; Methenolone; Middle Aged; Pancytopenia; Primary Myelofibrosis; Remission, Spontaneous; Virilism | 1979 |
6 other study(ies) available for methenolone and Remission--Spontaneous
Article | Year |
---|---|
[Prospective studies of effects of androstanes on aplastic anemia (author's transl)].
Topics: Adolescent; Adult; Androstanes; Anemia, Aplastic; Female; Fluoxymesterone; Humans; Male; Methenolone; Middle Aged; Oxymetholone; Prospective Studies; Remission, Spontaneous; Time Factors | 1978 |
[Treatment of aplastic anemia with androgenic anabolic steroids (oxymetholone or methenolone) (author's transl)].
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Drug Therapy, Combination; Female; Humans; Male; Methenolone; Middle Aged; Oxymetholone; Prognosis; Remission, Spontaneous | 1978 |
Treatment of disseminated carcinoma of the breast by metenolone enanthate.
Forty-three patients with disseminated or inoperable carcinoma of the breast were treated with Metenolone Enanthate (Primobolan Depot) with doses of 400 to 1 200 mg/week for at least 3 months. Objective remissions lasting longer than 3 months occurred in 8 out of 41 evaluable patients. Soft tissue metastases responsed best. Liver and brain metastases were unaffected. The therapeutic efficiency of Primobolan Depot is comparable to that of testosterone propionate but the agent is less virilising. Topics: Aged; Breast Neoplasms; Female; Hirsutism; Hoarseness; Humans; Libido; Lymphatic Metastasis; Methenolone; Middle Aged; Neoplasm Metastasis; Remission, Spontaneous | 1975 |
[Long term treatment of multiple myeloma].
Topics: Adenocarcinoma, Scirrhous; Autopsy; Bone Neoplasms; Cyclophosphamide; Female; Humans; Long-Term Care; Methenolone; Middle Aged; Multiple Myeloma; Neoplasm Metastasis; Neoplasms, Multiple Primary; Remission, Spontaneous; Sacrum; Skull; Stomach Neoplasms | 1973 |
Treatment of aplastic anaemia with methenolone.
Topics: Adult; Aged; Anemia, Aplastic; Bone Marrow Examination; Busulfan; Child, Preschool; Cholestasis; Female; Humans; Male; Megakaryocytes; Methenolone; Middle Aged; Multiple Myeloma; Remission, Spontaneous | 1972 |
Androstane therapy of aplastic anaemia.
Topics: Androstanes; Anemia, Aplastic; Bone Marrow Examination; Female; Fetal Hemoglobin; Follow-Up Studies; Humans; Male; Methenolone; Oxymetholone; Prognosis; Remission, Spontaneous | 1972 |